NCT02171767View on ClinicalTrials.gov

Safety and Tolerability of 4 Different Dosage Strengths of BIBW 2992 Tablets to Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2009

Conditions
Healthy
Interventions
DRUG

BIBW 2992 MA2 - single rising dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY